Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • PRO.MED.CS Praha

    PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    PRO.MED.CS Praha
    Telcska 1, Prague, 140 00, Czech Republic
    +420 241 013 111
    Contact PRO.MED.CS Praha
    Website

     Latest Content from PMHub 

    Behind the scenes: why we created ‘The participation equation’

    White Papers and Resources | November 28, 2025 | Cuttsy + Cuttsy

    Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.

    Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

    Press Releases | November 28, 2025 | Inizio

    As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

    Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

    Press Releases | November 27, 2025 | Cuttsy + Cuttsy

    Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

    Does real-world use of AI in systematic literature reviews result in time and cost savings?

    White Papers and Resources | November 27, 2025 | Amiculum

    By Manca Povsic and Emma Griffiths

    How DataGateway unified oncology data for real-world insights & market intelligence

    Press Releases | November 26, 2025 | Inizio

    Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

    Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

    Press Releases | November 26, 2025 | Inizio

    Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

    ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

    Press Releases | November 26, 2025 | Inizio

    Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

    Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?

    White Papers and Resources | November 21, 2025 | Amiculum

    By Emily Morton-West

    The Future of MSL Training – How Digital Technologies Are Shaping Success

    Press Releases | November 20, 2025 | Impetus Digital

    Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.

    Women Leaders Rewriting the Protocols of Rare Disease Care

    Press Releases | November 20, 2025 | Medscape Education

    The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...